WHO ICTRP trial

Amniotic membrane covering for the treatment of macular hole retinal detachment…

ChiCTR2500105586 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500105586
Public title Amniotic membrane covering for the treatment of macular hole retinal detachment in high myopia patients: a multicenter, randomized controlled study
Scientific title Amniotic membrane covering for the treatment of macular hole retinal detachment in high myopia patients: a multicenter, randomized controlled study
Primary sponsor The Eye Hospital of Wenzhou Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Macular hole retinal detachment due to high myopia
Interventions Amniotic group:The amniotic membrane covers the macular hole ;Inner limiting membrane group:The inner limiting membrane is flipped to cover/insert the macular hole
Registration date Jul 7, 2025
Target size Amniotic group:95;Inner limiting membrane group:95
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations